Association between soluble interleukin-2 receptor levels and disease severity in Complex Regional Pain Syndrome

Association between soluble interleukin-2 receptor levels and disease severity in Complex Regional Pain Syndrome - sIL-2R and CRPS severity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45772

Enrollment

Registered

2018-09-04

Start date

2018-10-16

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regionaal Pijnsyndroom Reflex Sympathetic Dystrophy Sudeck's Atrophy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The subject meets the new IASP clinical diagnostic criteria for CRPS {Harden, 2010} (

Exclusion criteria

Exclusion criteria: History of an auto-inflammatory or autoimmune disease. Current treatment with immunomodulating medication or treatment within the last 6 months. Ill in the past two weeks or at the time of the visit. Knowledge of or confirmed pregnancy.

Design outcomes

Primary

Measure	Time frame
The main study parameters are the blood sIL-2R level and CRPS severity score in patients with CRPS.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results